Nocardia infection in chronic granulomatous disease

Susan E. Dorman, Shireen V. Guide, Patricia S. Conville, Ellen S. DeCarlo, Harry L. Malech, John I. Gallin, Frank G. Witebsky, Steven M. Holland

Research output: Contribution to journalArticle

Abstract

To determine the clinical characteristics and outcome of Nocardia infection in patients with chronic granulomatous disease (CGD), we reviewed data on 28 episodes of Nocardia infection in 23 patients with CGD. All episodes involved pulmonary infection. The frequency of disseminated nocardiosis was 25% for the case series overall, but it was 56% among episodes in patients receiving neither interferon-γ (IFN-γ) nor sulfonamide prophylaxis. Patients receiving prophylaxis with IFN-γ and/or a sulfonamide were significantly less likely to have disseminated nocardiosis than were patients not receiving these medications, and no patient receiving both medications developed disseminated nocardiosis. One-third of the patients had concomitant fungal infections, and 2 patients had concomitant Legionella infections. The majority of patients were successfully treated with a sulfonamide-containing regimen, even though some patients had developed Nocardia infection while receiving sulfonamide prophylaxis. Nocardia infections in patients with CGD are not usually fatal if treated properly, and prophylaxis with IFN-γ and a sulfonamide may protect against dissemination.

Original languageEnglish (US)
Pages (from-to)390-394
Number of pages5
JournalClinical Infectious Diseases
Volume35
Issue number4
DOIs
StatePublished - Aug 15 2002
Externally publishedYes

Fingerprint

Nocardia Infections
Chronic Granulomatous Disease
Sulfonamides
Interferons
Legionella
Mycoses
Infection

ASJC Scopus subject areas

  • Immunology

Cite this

Dorman, S. E., Guide, S. V., Conville, P. S., DeCarlo, E. S., Malech, H. L., Gallin, J. I., ... Holland, S. M. (2002). Nocardia infection in chronic granulomatous disease. Clinical Infectious Diseases, 35(4), 390-394. https://doi.org/10.1086/341416

Nocardia infection in chronic granulomatous disease. / Dorman, Susan E.; Guide, Shireen V.; Conville, Patricia S.; DeCarlo, Ellen S.; Malech, Harry L.; Gallin, John I.; Witebsky, Frank G.; Holland, Steven M.

In: Clinical Infectious Diseases, Vol. 35, No. 4, 15.08.2002, p. 390-394.

Research output: Contribution to journalArticle

Dorman, SE, Guide, SV, Conville, PS, DeCarlo, ES, Malech, HL, Gallin, JI, Witebsky, FG & Holland, SM 2002, 'Nocardia infection in chronic granulomatous disease', Clinical Infectious Diseases, vol. 35, no. 4, pp. 390-394. https://doi.org/10.1086/341416
Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL, Gallin JI et al. Nocardia infection in chronic granulomatous disease. Clinical Infectious Diseases. 2002 Aug 15;35(4):390-394. https://doi.org/10.1086/341416
Dorman, Susan E. ; Guide, Shireen V. ; Conville, Patricia S. ; DeCarlo, Ellen S. ; Malech, Harry L. ; Gallin, John I. ; Witebsky, Frank G. ; Holland, Steven M. / Nocardia infection in chronic granulomatous disease. In: Clinical Infectious Diseases. 2002 ; Vol. 35, No. 4. pp. 390-394.
@article{2b2b25e4ae37475c9385c89d1a25d8da,
title = "Nocardia infection in chronic granulomatous disease",
abstract = "To determine the clinical characteristics and outcome of Nocardia infection in patients with chronic granulomatous disease (CGD), we reviewed data on 28 episodes of Nocardia infection in 23 patients with CGD. All episodes involved pulmonary infection. The frequency of disseminated nocardiosis was 25{\%} for the case series overall, but it was 56{\%} among episodes in patients receiving neither interferon-γ (IFN-γ) nor sulfonamide prophylaxis. Patients receiving prophylaxis with IFN-γ and/or a sulfonamide were significantly less likely to have disseminated nocardiosis than were patients not receiving these medications, and no patient receiving both medications developed disseminated nocardiosis. One-third of the patients had concomitant fungal infections, and 2 patients had concomitant Legionella infections. The majority of patients were successfully treated with a sulfonamide-containing regimen, even though some patients had developed Nocardia infection while receiving sulfonamide prophylaxis. Nocardia infections in patients with CGD are not usually fatal if treated properly, and prophylaxis with IFN-γ and a sulfonamide may protect against dissemination.",
author = "Dorman, {Susan E.} and Guide, {Shireen V.} and Conville, {Patricia S.} and DeCarlo, {Ellen S.} and Malech, {Harry L.} and Gallin, {John I.} and Witebsky, {Frank G.} and Holland, {Steven M.}",
year = "2002",
month = "8",
day = "15",
doi = "10.1086/341416",
language = "English (US)",
volume = "35",
pages = "390--394",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Nocardia infection in chronic granulomatous disease

AU - Dorman, Susan E.

AU - Guide, Shireen V.

AU - Conville, Patricia S.

AU - DeCarlo, Ellen S.

AU - Malech, Harry L.

AU - Gallin, John I.

AU - Witebsky, Frank G.

AU - Holland, Steven M.

PY - 2002/8/15

Y1 - 2002/8/15

N2 - To determine the clinical characteristics and outcome of Nocardia infection in patients with chronic granulomatous disease (CGD), we reviewed data on 28 episodes of Nocardia infection in 23 patients with CGD. All episodes involved pulmonary infection. The frequency of disseminated nocardiosis was 25% for the case series overall, but it was 56% among episodes in patients receiving neither interferon-γ (IFN-γ) nor sulfonamide prophylaxis. Patients receiving prophylaxis with IFN-γ and/or a sulfonamide were significantly less likely to have disseminated nocardiosis than were patients not receiving these medications, and no patient receiving both medications developed disseminated nocardiosis. One-third of the patients had concomitant fungal infections, and 2 patients had concomitant Legionella infections. The majority of patients were successfully treated with a sulfonamide-containing regimen, even though some patients had developed Nocardia infection while receiving sulfonamide prophylaxis. Nocardia infections in patients with CGD are not usually fatal if treated properly, and prophylaxis with IFN-γ and a sulfonamide may protect against dissemination.

AB - To determine the clinical characteristics and outcome of Nocardia infection in patients with chronic granulomatous disease (CGD), we reviewed data on 28 episodes of Nocardia infection in 23 patients with CGD. All episodes involved pulmonary infection. The frequency of disseminated nocardiosis was 25% for the case series overall, but it was 56% among episodes in patients receiving neither interferon-γ (IFN-γ) nor sulfonamide prophylaxis. Patients receiving prophylaxis with IFN-γ and/or a sulfonamide were significantly less likely to have disseminated nocardiosis than were patients not receiving these medications, and no patient receiving both medications developed disseminated nocardiosis. One-third of the patients had concomitant fungal infections, and 2 patients had concomitant Legionella infections. The majority of patients were successfully treated with a sulfonamide-containing regimen, even though some patients had developed Nocardia infection while receiving sulfonamide prophylaxis. Nocardia infections in patients with CGD are not usually fatal if treated properly, and prophylaxis with IFN-γ and a sulfonamide may protect against dissemination.

UR - http://www.scopus.com/inward/record.url?scp=0037102955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037102955&partnerID=8YFLogxK

U2 - 10.1086/341416

DO - 10.1086/341416

M3 - Article

C2 - 12145721

AN - SCOPUS:0037102955

VL - 35

SP - 390

EP - 394

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 4

ER -